Targeting CD73 and correcting adenosinergic signaling in critically ill patients.
Saved in:
| Title: | Targeting CD73 and correcting adenosinergic signaling in critically ill patients. |
|---|---|
| Authors: | Lunderberg JM; Department of Anesthesiology, Center for Inflammation Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States., Spicer AJ; Faron Pharmaceuticals Ltd., Turku, Finland., Cassavaugh J; Department of Anesthesiology, Center for Inflammation Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States., Jalkanen J; Faron Pharmaceuticals Ltd., Turku, Finland., Haskó G; Department of Anesthesiology, Columbia University, New York, NY, United States., Robson SC; Department of Anesthesiology, Center for Inflammation Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Jan 12; Vol. 16, pp. 1601481. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
